The9 LtdNASDAQ:NCTYNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE6.0800
- TODAY'S CHANGE (%)0.0800 (1.3333%)
- Bid / Lots5.7000/ 3
- Ask / Lots6.1400/ 1
- Open / Previous Close6.0000 / 6.0000
- Day Range
- 52 Week Range
- Volume19,407
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NCTY |
|---|---|---|
| 09:32 ET | 1430 | 6 |
| 09:36 ET | 500 | 5.99 |
| 09:43 ET | 171 | 6.1 |
| 09:45 ET | 500 | 6.19 |
| 10:12 ET | 800 | 6.1 |
| 10:26 ET | 100 | 6.1143 |
| 10:33 ET | 2686 | 6.1 |
| 10:50 ET | 200 | 6.101 |
| 10:55 ET | 100 | 6.19 |
| 10:57 ET | 140 | 6.131 |
| 11:00 ET | 400 | 6.123 |
| 11:15 ET | 105 | 6.12 |
| 11:20 ET | 4447 | 6.15 |
| 11:44 ET | 744 | 6.15 |
| 11:45 ET | 100 | 6.15 |
| 12:05 ET | 535 | 6.1419 |
| 12:07 ET | 100 | 6.09 |
| 12:09 ET | 800 | 6.0656 |
| 12:59 ET | 100 | 6.1 |
| 03:21 ET | 200 | 5.6601 |
| 03:48 ET | 1323 | 5.814 |
| 03:57 ET | 100 | 6.04 |
| 03:59 ET | 242 | 5.89 |
Apr 15, 2024
The9 Limited Achieved 66% Increase in Net Revenues and Turned Net Loss into Net Income for the Year Ended December 31, 2023, from 10:41PM ET on Monday Apr 15, 2024 by Dow Jones
10:41PM ET on Monday Apr 15, 2024 by Dow JonesA New Generation of Antidepressant Drug Precision Treatment Based on Revolutionary AI Technology is Born, from 6:00AM ET on Monday Apr 15, 2024 by Dow Jones
6:00AM ET on Monday Apr 15, 2024 by Dow Jones
Mar 26, 2024
/C O R R E C T I O N: The9 Signed a Definitive Share Purchase Agreement to Invest in GenAI LLM Digital Precision Medicine Platform for Brain Disease WM Therapeutic, from 10:01AM ET on Tuesday Mar 26, 2024 by Dow Jones
10:01AM ET on Tuesday Mar 26, 2024 by Dow Jones*DJ The9 Signs Definitive Agreement to Invest in GenAI LLM Digital Precision Medicine Platform for Brain Disease WM Therapeutic, from 8:00AM ET on Tuesday Mar 26, 2024 by Dow Jones
8:00AM ET on Tuesday Mar 26, 2024 by Dow JonesThe9 Signed a Definitive Share Purchase Agreement to Invest in GenAI LLM Digital Precision Medicine Platform for Brain Disease WM Therapeutic, from 8:00AM ET on Tuesday Mar 26, 2024 by Dow Jones
8:00AM ET on Tuesday Mar 26, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
The9 Ltd | 34.0M | -0.2x | --- |
Everything Blockchain Inc | 6.6M | -0.4x | --- |
Data443 Risk Mitigation Inc | 1.5M | 0.0x | --- |
Netplex Group Inc | 30.0 | 0.0x | --- |
Freeze Tag Inc | 765.6K | -3.4x | --- |
Secured Services Inc | 20.0 | 0.0x | --- |
Company Information
The9 Ltd is a China-based holding company principally engaged in the Internet game business. The Company's main businesses are the operation and development of mobile phones and computer games. The Company offers online games, including massively multiplayer online role playing games (MMORPGs), massively multiplayer online first-person shooter games (MMOFPSs), Web games, social games, mobile games and television games. The Company's main products include Legend of Immortals, The World of Kings, CrossFire and others. The Company is also engaged in cryptocurrency mining and operations, as well as the development of non-fungible token platform NFTSTAR. The Company conducts business through subsidiaries in mainland China, the United States, Singapore and Hong Kong.
Contact Information
- Headquarters
- 17 Floor No. 130 Wu Song Road, Hong Kou DistrictSHANGHAI, SHA, China 200080
- Phone
- 215-172-9999
- Fax
- 215-172-9500
Executives
- Chairman of the Board, Chief Executive Officer, Co-Founder
- Jun Zhu
- President
- Chris Shen
- Chief Finance Officer, Director
- Kwok Ho Lai
- Independent Director
- Kwok Keung Chau
- Independent Director
- Davin Mackenzie
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $34.0M |
|---|---|
Revenue (TTM) | $22.8M |
Shares Outstanding | 558.4K |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.92 |
EPS | $-33.33 |
Book Value | $2.18 |
P/E Ratio | -0.2x |
Price/Sales (TTM) | 1.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -421.62% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
